玻璃体蛋白质组学与糖尿病视网膜病变
Vitreous proteomics and diabetic retinopathy.
作者信息
Walia Saloni, Clermont Allen C, Gao Ben-Bo, Aiello Lloyd Paul, Feener Edward P
机构信息
Joslin Diabetes Center, Boston, MA, USA.
出版信息
Semin Ophthalmol. 2010 Sep-Nov;25(5-6):289-94. doi: 10.3109/08820538.2010.518912.
Abstract
Diabetic retinopathy is the major cause of acquired blindness in working-age adults. Studies of the vitreous proteome have provided insights into the etiology of diabetic retinopathy and suggested potential molecular targets for treatments. Further characterization of the protein changes associated with the progression of this disease may suggest additional therapeutic approaches as well as reveal novel factors that may be useful in predicting risk and functional outcomes of interventional therapies. This article provides an overview of the various techniques used for proteomic analysis of the vitreous and details results from various studies evaluating vitreous of diabetic patients using the proteomic approach.
摘要
糖尿病视网膜病变是工作年龄成年人后天失明的主要原因。对玻璃体蛋白质组的研究为糖尿病视网膜病变的病因提供了见解，并提出了潜在的治疗分子靶点。对与该疾病进展相关的蛋白质变化进行进一步表征，可能会提出额外的治疗方法，并揭示可能有助于预测介入治疗风险和功能结果的新因素。本文概述了用于玻璃体蛋白质组分析的各种技术，并详细介绍了使用蛋白质组学方法评估糖尿病患者玻璃体的各项研究结果。
相似文献
1
Vitreous proteomics and diabetic retinopathy.玻璃体蛋白质组学与糖尿病视网膜病变
Semin Ophthalmol. 2010 Sep-Nov;25(5-6):289-94. doi: 10.3109/08820538.2010.518912.
2
Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.无糖尿病视网膜病变的糖尿病患者和增殖性糖尿病视网膜病变的糖尿病患者玻璃体液蛋白质组的特征分析
J Proteome Res. 2008 Jun;7(6):2516-25. doi: 10.1021/pr800112g. Epub 2008 Apr 24.
3
Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.增殖性糖尿病视网膜病变患者与非糖尿病患者玻璃体蛋白质组分析。
Proteomics. 2007 Nov;7(22):4203-15. doi: 10.1002/pmic.200700745.
4
Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis.利用基于荧光的差异凝胶电泳分析鉴定糖尿病性黄斑水肿的新致病候选物。
Diabetes Metab Res Rev. 2013 Sep;29(6):499-506. doi: 10.1002/dmrr.2419.
5
Diabetes Induced Alterations in Murine Vitreous Proteome Are Mitigated by IL-6 Trans-Signaling Inhibition.IL-6 转导信号抑制减轻糖尿病诱导的小鼠玻璃体蛋白质组改变。
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):2. doi: 10.1167/iovs.61.11.2.
6
Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy.糖尿病视网膜病变中血管内皮生长因子基因多态性与玻璃体蛋白质组变化
Semin Ophthalmol. 2013 Sep-Nov;28(5-6):347-54. doi: 10.3109/08820538.2013.825284.
7
Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.2型糖尿病增殖性糖尿病视网膜病变患者玻璃体的定量蛋白质组学分析
BMC Ophthalmol. 2018 Jun 26;18(1):151. doi: 10.1186/s12886-018-0821-3.
8
A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.综述：视网膜动脉阻塞、视网膜静脉阻塞、糖尿病视网膜病变及获得性黄斑疾病中的蛋白质组学
Int J Mol Sci. 2017 Apr 28;18(5):907. doi: 10.3390/ijms18050907.
9
Differential expression of vitreous proteins in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中玻璃体蛋白的差异表达
Curr Eye Res. 2006 Mar;31(3):231-40. doi: 10.1080/02713680600557030.
10
Proteomic analysis of vitreous from diabetic macular edema.糖尿病性黄斑水肿玻璃体的蛋白质组学分析
Exp Eye Res. 2005 Aug;81(2):176-82. doi: 10.1016/j.exer.2005.01.020.
引用本文的文献
1
Alterations in Tear Proteomes of Adults with Pre-Diabetes and Type 2 Diabetes Mellitus but Without Diabetic Retinopathy.无糖尿病视网膜病变的糖尿病前期和2型糖尿病成年患者泪液蛋白质组的变化
Proteomes. 2025 Jul 1;13(3):29. doi: 10.3390/proteomes13030029.
2
Proteomic Analysis of Aqueous Humor Identified Clinically Relevant Molecular Targets for Neovascular Complications in Diabetic Retinopathy.房水的蛋白质组学分析确定了糖尿病视网膜病变新生血管并发症的临床相关分子靶点。
Mol Cell Proteomics. 2025 Apr;24(4):100953. doi: 10.1016/j.mcpro.2025.100953. Epub 2025 Mar 19.
3
Vitreomacular traction in diabetic retinopathy.糖尿病性视网膜病变中的玻璃体黄斑牵引。
Jpn J Ophthalmol. 2024 Jan;68(1):12-18. doi: 10.1007/s10384-023-01034-2. Epub 2023 Nov 25.
4
Mass Spectrometry-Based Vitreous Proteomics: Validated Methods and Analysis Pipeline.基于质谱的玻璃体蛋白质组学：验证方法和分析流程。
Methods Mol Biol. 2023;2678:157-167. doi: 10.1007/978-1-0716-3255-0_11.
5
Pursuing Diabetic Nephropathy through Aqueous Humor Proteomics Analysis.通过房水蛋白质组学分析来研究糖尿病肾病。
Oxid Med Cell Longev. 2022 Sep 29;2022:5945828. doi: 10.1155/2022/5945828. eCollection 2022.
6
Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook.增殖性糖尿病视网膜病变玻璃体的蛋白质组学分析：既往研究与未来展望
J Clin Med. 2021 May 25;10(11):2309. doi: 10.3390/jcm10112309.
7
Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory Diseases.用于“揭示”眼内炎性疾病的眼内活检与免疫分子病理学
J Clin Med. 2019 Oct 19;8(10):1733. doi: 10.3390/jcm8101733.
8
Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.血管内皮生长因子诱导视网膜毛细血管内皮细胞中血管黏附蛋白-1的蛋白水解切割。
Jpn J Ophthalmol. 2018 Mar;62(2):256-264. doi: 10.1007/s10384-017-0555-4. Epub 2018 Feb 1.
9
A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.综述：视网膜动脉阻塞、视网膜静脉阻塞、糖尿病视网膜病变及获得性黄斑疾病中的蛋白质组学
Int J Mol Sci. 2017 Apr 28;18(5):907. doi: 10.3390/ijms18050907.
10
Diabetic Retinopathy: Battling the Global Epidemic.糖尿病视网膜病变：对抗全球流行疾病
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6669-6682. doi: 10.1167/iovs.16-21031.
本文引用的文献
1
Proteomics as a research tool in clinical and experimental ophthalmology.蛋白质组学作为临床和实验眼科研究的工具。
Proteomics Clin Appl. 2008 May;2(5):762-75. doi: 10.1002/prca.200780094.
2
Mass spectrometry-based label-free quantitative proteomics.基于质谱的无标记定量蛋白质组学
J Biomed Biotechnol. 2010;2010:840518. doi: 10.1155/2010/840518. Epub 2009 Nov 10.
3
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.雷珠单抗治疗糖尿病性黄斑水肿（READ-2）研究的主要终点（六个月）结果。
Ophthalmology. 2009 Nov;116(11):2175-81.e1. doi: 10.1016/j.ophtha.2009.04.023. Epub 2009 Aug 22.
4
Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.玻璃体内注射贝伐单抗治疗难治性人工晶状体眼黄斑囊样水肿：泛美视网膜协作研究组的结果
Ophthalmology. 2009 Aug;116(8):1481-7, 1487.e1. doi: 10.1016/j.ophtha.2009.04.006. Epub 2009 Jul 9.
5
Briefings in bioinformatics.
Brief Bioinform. 2009 Jul;10(4):343-4. doi: 10.1093/bib/bbp031.
6
Proteomics by mass spectrometry: approaches, advances, and applications.基于质谱分析的蛋白质组学：方法、进展与应用
Annu Rev Biomed Eng. 2009;11:49-79. doi: 10.1146/annurev-bioeng-061008-124934.
7
Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.糖尿病患者玻璃体液中载脂蛋白A-I和载脂蛋白H水平升高以及视网膜中的过表达。
Arch Ophthalmol. 2008 Aug;126(8):1076-81. doi: 10.1001/archopht.126.8.1076.
8
Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.无糖尿病视网膜病变的糖尿病患者和增殖性糖尿病视网膜病变的糖尿病患者玻璃体液蛋白质组的特征分析
J Proteome Res. 2008 Jun;7(6):2516-25. doi: 10.1021/pr800112g. Epub 2008 Apr 24.
9
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗与曲安奈德治疗持续性弥漫性糖尿病性黄斑水肿的对比治疗评估
Am J Ophthalmol. 2008 May;145(5):854-61. doi: 10.1016/j.ajo.2007.12.031. Epub 2008 Mar 6.
10
Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics.蛋白质组学中串联质谱的数据分析与生物信息学工具
Physiol Genomics. 2008 Mar 14;33(1):18-25. doi: 10.1152/physiolgenomics.00298.2007. Epub 2008 Jan 22.
Zotero 插件